Cart (0 Items)
Your cart is currently empty.
View ProductsBrand | ProteoGenix |
---|---|
Product type | Elisa assay kits |
Size | 96T |
Product name | Indatuximab ELISA Kit |
---|---|
Delivery condition | Blue ice (+4°) |
Storage condition | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
Brand | ProteoGenix |
Size | 96T |
Reference | KPTX205 |
Note | For research use only. |
Sample type | Plasma, Serum |
Immunogen | Indatuximab |
Indatuximab is a monoclonal antibody that has been developed as a therapeutic agent for the treatment of multiple myeloma, a type of blood cancer. It specifically targets a protein called CD138, which is highly expressed on the surface of multiple myeloma cells. The use of Indatuximab has shown promising results in clinical trials and is now available for use in patients. In order to accurately measure the levels of Indatuximab in patient samples, an ELISA (enzyme-linked immunosorbent assay) kit has been developed. In this article, we will discuss the structure, activity, and application of the Indatuximab ELISA Kit.
The Indatuximab ELISA Kit consists of several components including microtiter plates, wash buffer, sample diluent, standards, controls, detection antibody, and substrate solution. The microtiter plates are coated with a specific antigen that binds to Indatuximab. The wash buffer is used to remove any unbound substances from the microtiter plates. The sample diluent is used to dilute patient samples and the standards, which are known concentrations of Indatuximab, are used to create a standard curve for quantification. The controls are used to ensure the accuracy and precision of the assay. The detection antibody is specific for Indatuximab and is conjugated with an enzyme that produces a color change when the substrate solution is added. The intensity of the color is directly proportional to the amount of Indatuximab present in the sample.
The Indatuximab ELISA Kit works on the principle of a sandwich immunoassay. The microtiter plates are coated with an antigen that binds specifically to Indatuximab. When patient samples are added to the microtiter plate, any Indatuximab present in the sample will bind to the coated antigen. After washing away any unbound substances, the detection antibody is added, which binds to the other end of Indatuximab. The enzyme conjugated to the detection antibody then catalyzes a reaction with the substrate solution, resulting in a color change. The intensity of the color is measured using a spectrophotometer and is directly proportional to the amount of Indatuximab present in the sample.
The Indatuximab ELISA Kit has several applications in the field of oncology. It is primarily used to measure the levels of Indatuximab in patient samples, which helps in monitoring the effectiveness of the treatment. It can also be used to determine the pharmacokinetics of Indatuximab, i.e. how the drug is absorbed, distributed, metabolized, and eliminated from the body. This information can aid in determining the optimal dosing regimen for individual patients. In addition, the Indatuximab ELISA Kit can also be used in preclinical and clinical studies to evaluate the pharmacodynamics of Indatuximab, i.e. how the drug affects its target protein and the overall disease process.
In summary, the Indatuximab ELISA Kit is a valuable tool for measuring the levels of Indatuximab in patient samples. Its structure, activity, and application make it a reliable and accurate method for monitoring the effectiveness of Indatuximab treatment. With the increasing use of Indatuximab in multiple myeloma patients, the Indatuximab ELISA Kit will continue to play a crucial role in improving patient outcomes.
Send us a message from the form below
Reviews
There are no reviews yet.